ArticleInternational journal of clinical and experimental pathology2013

RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.

Zhi-Hong Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.